Terms: = Endocrine gland cancer AND PAX8, ENSG00000125618, 7849
588 results:
1. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.
Gu H; Wang J; Ran W; Li G; Hu S; Zhao H; Wang X; Wang J
J Pathol Clin Res; 2024 Mar; 10(2):e356. PubMed ID: 38602501
[TBL] [Abstract] [Full Text] [Related]
2. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
3. Liver Mass as First-Time Diagnosis of Sarcomatoid Anaplastic Thyroid Carcinoma: A Rare Malignancy Presenting at an Unexpected Body Site.
Kamashki A; Rivera M; Sturgis CD
Am J Case Rep; 2023 Dec; 24():e941838. PubMed ID: 38041397
[TBL] [Abstract] [Full Text] [Related]
4. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
[TBL] [Abstract] [Full Text] [Related]
5. Divergent Lineage Markers in Anaplastic Thyroid Carcinoma.
Mneimneh WS; Asa SL
Am J Surg Pathol; 2024 Feb; 48(2):230-237. PubMed ID: 37972932
[TBL] [Abstract] [Full Text] [Related]
6. Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases.
Gao Y; Pan Y; Luo Y; Cheng R; Zhai Q
Ann Diagn Pathol; 2023 Dec; 67():152221. PubMed ID: 37925863
[TBL] [Abstract] [Full Text] [Related]
7. Neoplasms in Struma Ovarii: A Review.
Tondi Resta I; Sande CM; LiVolsi VA
Endocr Pathol; 2023 Dec; 34(4):455-460. PubMed ID: 37864665
[TBL] [Abstract] [Full Text] [Related]
8. Thyroid hormone receptor α1: a novel regulator of thyroid cancer cell differentiation.
Hwang E; Doolittle WKL; Zhu YJ; Zhu X; Zhao L; Yu Y; Cheng SY
Oncogene; 2023 Oct; 42(41):3075-3086. PubMed ID: 37634007
[TBL] [Abstract] [Full Text] [Related]
9. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
10. Non-hyalinizing trabecular thyroid adenoma: a novel thyroid tumor with diagnostic pitfalls of hyalinizing trabecular adenoma and medullary thyroid carcinoma.
Hirokawa M; Matsuse M; Mitsutake N; Suzuki A; Higuchi M; Hayashi T; Kamma H; Miyauchi A; Akamizu T
Diagn Pathol; 2023 Jun; 18(1):74. PubMed ID: 37340328
[TBL] [Abstract] [Full Text] [Related]
11. Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells.
Zhang GQ; Xi C; Shen CT; Song HJ; Luo QY; Qiu ZL
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37260320
[TBL] [Abstract] [Full Text] [Related]
12. Establishment of a novel model of endometriosis-associated ovarian cancer by transplanting uterine tissue from Arid1a/Pten knockout mice.
Ono M; Miyamoto T; Asaka R; Uchikawa J; Ando H; Tanaka Y; Shinagawa M; Yokokawa Y; Asaka S; Wang TL; Shih IM; Shiozawa T
Sci Rep; 2023 May; 13(1):8348. PubMed ID: 37221199
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic recurrence of lung adenocarcinoma in thyroid clinically masquerading as primary thyroid cancer and immunohistochemically positive for thyroglobulin.
Yorita K; Hokimoto N; Tanida N; Matsuoka H
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37208007
[TBL] [Abstract] [Full Text] [Related]
14. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
[No Abstract] [Full Text] [Related]
15. High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.
Travaglino A; Santoro A; Arciuolo D; Raffone A; Scaglione G; D'Alessandris N; Valente M; Sfregola S; Fulgione C; Onori ME; Minucci A; Zannoni GF
Virchows Arch; 2023 Dec; 483(6):879-883. PubMed ID: 37166561
[TBL] [Abstract] [Full Text] [Related]
16. Mixed Ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components: A Rare Group of Tumors Demonstrating the Phenotypic Plasticity of the Mullerian Epithelial Cell.
Chui MH; Ellenson LH
Am J Surg Pathol; 2023 Jul; 47(7):756-765. PubMed ID: 37125505
[TBL] [Abstract] [Full Text] [Related]
17. pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens.
Chi Z; Xu J; Karamchandani DM; Peng L
Diagn Pathol; 2023 Apr; 18(1):54. PubMed ID: 37098593
[TBL] [Abstract] [Full Text] [Related]
18.
Bulutay P; Vatansever D; Taskiran C; Mericoz CA; Tokat F; Kapucuoglu N; Kulac I
Indian J Pathol Microbiol; 2023; 66(2):392-395. PubMed ID: 37077094
[TBL] [Abstract] [Full Text] [Related]
19. Understanding and Overcoming the Pitfalls in Cytopathological Diagnosis of Hyalinizing Trabecular Tumor of Thyroid.
Mahjabin F; Gonsalves C; Drew PA; Mukhtar F; Leon ME
Int J Surg Pathol; 2024 Feb; 32(1):91-96. PubMed ID: 37050854
[TBL] [Abstract] [Full Text] [Related]
20. Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high-grade malignancy?
Murata SI; Matsuzaki I; Kishimoto M; Katsuki N; Onishi T; Hirokawa M; Kojima F
Pathol Int; 2023 May; 73(5):207-211. PubMed ID: 37042564
[TBL] [Abstract] [Full Text] [Related]
[Next]